查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1652742

肝臟移植市场：2025 年至 2032 年全球产业分析、规模、份额、成长、趋势与预测

Liver Transplantation Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 217 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份有关全球肝臟移植市场的详尽报告。该报告对市场驱动因素、趋势、机会和挑战等关键市场动态进行了全面的分析，并对市场结构提供了深入的见解。

关键见解

  • 肝臟移植市场规模（2025年预测）：19.01亿美元
  • 预计市场价值（2032F）：30.101亿美元
  • 全球市场成长率（2025-2032 年复合年增长率）：6.8%

肝臟移植市场报告内容：

肝臟移植市场包括用于治疗肝硬化、肝细胞癌和急性肝功能衰竭等严重肝病的肝臟移植的各种程序、技术和捐赠者来源。该市场包括尸体和活体肝臟移植技术，外科手术、免疫抑制剂和术后护理的进步正在推动其成长。肝病发生率的不断上升以及器官捐赠接受度的不断提高推动了市场扩张。

市场成长动力：

有几个关键因素推动全球肝臟移植市场的发展。因饮酒、病毒性肝炎和非酒精性脂肪性肝病（NAFLD）导致的肝病发生率不断上升，大大增加了肝臟移植的需求。此外，微创植入和机器人辅助手术等手术技术的进步提高了成功率和患者的治疗效果。新型免疫抑制剂的开发也降低了器官排斥的风险，进一步推动了市场的成长。此外，政府推动器官捐赠和移植基础设施发展的倡议和意识提升计划预计将推动市场扩张。

市场限制：

儘管成长前景看好，但肝臟移植市场仍面临若干挑战。肝臟移植的费用高昂，包括术前、手术和术后费用，仍然是一个主要障碍，尤其是在开发中国家。捐赠器官的有限供应进一步限制了市场的成长，导致有需要的病人需要长时间等候，死亡率也上升。此外，感染疾病、器官排斥和免疫抑制治疗的副作用等移植后併发症对移植的成功构成了挑战。有关器官采购的严格监管要求和道德问题也影响了市场扩张。

市场机会：

器官保存和移植技术的进步为市场提供了巨大的机会。机器灌注技术的引入有望提高供肝的存活率和延长供肝的保存期，从而提高移植的成功率。 3D 列印肝组织和干细胞疗法等生物工程和再生医学的日益普及为传统移植提供了一个有希望的替代方案。此外，对移植中心的投资增加、医疗保健组织之间的合作以及促进活体捐赠计划的倡议提供了新的成长途径。新兴经济体扩大医疗保健覆盖率和优惠的报销政策也促进了市场的发展。

本报告探讨的关键问题

  • 推动全球肝臟移植市场成长的关键因素有哪些？
  • 科技进步如何影响肝臟移植市场的竞争格局？
  • 肝臟移植患者和医疗保健提供者面临的主要挑战是什么？
  • 谁是肝臟移植市场的关键参与者，他们采取什么策略来保持竞争力？
  • 全球肝臟移植市场有哪些新兴趋势与前景？

目录

第一章执行摘要

第二章 市场概况

  • 市场范围和定义
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
    • 任务
    • 主要趋势
  • 产品类型生命週期分析
  • 肝臟移植市场：价值链
    • 原物料供应商名单
    • 製造商列表
    • 经销商名单
    • 应用程式列表
    • 盈利分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长前景
    • 全球母市场概览
  • 预测因子－相关性和影响力
  • 监管和技术格局

第 3 章 全球肝臟移植市场展望：历史（2019-2023）与预测（2025-2032）

  • 主要亮点
    • 市场规模（单位）预测
    • 市场规模及与前一年同期比较率
    • 绝对商机
  • 市场规模（百万美元）分析及预测
    • 2019 年至 2023 年历史市场规模分析
    • 目前市场规模预测，2025-2032
  • 全球肝臟移植市场展望：产品类型
    • 简介/主要发现
    • 2019 年至 2023 年历史市场规模（百万美元）和销售（单位）分析（按产品类型）
    • 当前市场规模（百万美元）和销售（单位）预测，2025-2032 年，按产品类型划分
      • 器官保存解决方案
      • 免疫抑制剂
      • 其他的
  • 市场吸引力分析：产品类型
  • 全球肝臟移植市场展望：治疗类型
    • 简介/主要发现
    • 2019 年至 2023 年按治疗类型分類的历史市场规模（百万美元）和销售量（单位）分析
    • 当前市场规模（百万美元）和销售（单位）预测，2025-2032 年，按治疗类型划分
      • 肝臟移植手术
      • 术后抗排斥治疗
      • Cyclosporine
      • Tacrolimus
      • Sirolimus泼尼松Azathioprine
      • Mycophenolate Mofetil
  • 市场吸引力分析：治疗类型
  • 全球肝臟移植市场展望：最终用途
    • 简介/主要发现
    • 2019 年至 2023 年历史市场规模（百万美元）和销售（单位）分析，按最终用途
    • 当前市场规模（百万美元）和 2025-2032 年销售（单位）预测（按最终用途）
      • 医院
      • 成人肝臟移植中心
      • 门诊手术中心
  • 市场吸引力分析：最终用途

4. 全球肝臟移植市场展望-区域

  • 主要亮点
  • 2019 年至 2023 年按地区分類的历史市场规模（百万美元）和销售量（单位）分析
  • 2025 年至 2032 年各地区目前市场规模（百万美元）及销售量（单位）预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和太平洋
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

第 5 章北美肝臟移植市场展望：历史（2019-2023 年）与预测（2025-2032 年）

6. 欧洲肝臟移植市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 7 章东亚肝臟移植市场展望：历史（2019-2023 年）与预测（2025-2032 年）

8. 南亚和大洋洲肝臟移植市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第 9 章拉丁美洲肝臟移植市场展望：历史（2019-2023 年）与预测（2025-2032 年）

第 10 章中东和非洲肝臟移植市场展望：历史（2019-2023 年）和预测（2025-2032 年）

第十一章 竞争格局

  • 2024 年市场占有率分析
  • 市场结构
    • 市场竞争加剧图
    • 竞争性免疫抑制剂
    • 表观产品体积
  • 公司简介（详情－概述、财务状况、策略、最新发展）
    • Allosource
    • Conatus Pharmaceuticals Inc.
    • Digna Biotech SL
    • Dompe Farmaceutici SpA
    • Isogenis, Inc.
    • RedHill Biopharma Ltd.
    • Thompson Surgical
    • Integra Life Sciences
    • Baxter International Inc.
    • XVIVO
    • VirTech Bio
    • Vital Therapies
    • HepaTx

第十二章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP33816

Persistence Market Research has recently published an extensive report on the global Liver Transplantation Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • Liver Transplantation Market Size (2025E): USD 1901 Mn
  • Projected Market Value (2032F): USD 3010.1 Mn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.8%

Liver Transplantation Market - Report Scope:

The Liver Transplantation Market encompasses a range of procedures, technologies, and donor sources for liver transplants, primarily used to treat severe liver diseases, including cirrhosis, hepatocellular carcinoma, and acute liver failure. The market involves both cadaveric and living donor transplantation techniques, with advancements in surgical procedures, immunosuppressive drugs, and post-operative care driving growth. The increasing prevalence of liver diseases, coupled with the growing acceptance of organ donation, is fueling market expansion.

Market Growth Drivers:

Several key factors are driving the global Liver Transplantation Market. The rising incidence of liver diseases due to alcohol consumption, viral hepatitis, and non-alcoholic fatty liver disease (NAFLD) has significantly increased the demand for liver transplants. Moreover, advancements in surgical techniques, including minimally invasive transplantation and robotic-assisted surgeries, have improved success rates and patient outcomes. The development of new immunosuppressive drugs has also reduced the risk of organ rejection, further supporting market growth. Additionally, government initiatives and awareness programs promoting organ donation and transplantation infrastructure development are expected to boost market expansion.

Market Restraints:

Despite promising growth prospects, the Liver Transplantation Market faces several challenges. The high cost of liver transplantation, including pre-operative, surgical, and post-operative expenses, remains a significant barrier, particularly in developing countries. The limited availability of donor organs further restricts market growth, leading to long waiting lists and increased mortality rates among patients in need. Additionally, post-transplant complications such as infections, organ rejection, and side effects of immunosuppressive therapy pose challenges to successful transplant outcomes. Stringent regulatory requirements and ethical concerns regarding organ procurement also impact market expansion.

Market Opportunities:

The market presents significant opportunities driven by technological advancements in organ preservation and transplant techniques. The introduction of machine perfusion technology, which enhances the viability of donor livers and extends preservation time, is expected to improve transplant success rates. The increasing adoption of bioengineering and regenerative medicine, including 3D-printed liver tissues and stem cell therapy, offers promising alternatives to traditional transplantation. Furthermore, growing investments in transplant centers, collaborations between healthcare organizations, and initiatives promoting living donor programs provide new growth avenues. Expanding healthcare access in emerging economies and favorable reimbursement policies also contribute to market development.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the Liver Transplantation Market globally?
  • How are technological advancements influencing the competitive landscape of the Liver Transplantation Market?
  • What are the major challenges faced by liver transplant patients and healthcare providers?
  • Who are the key players in the Liver Transplantation Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global Liver Transplantation Market?

Competitive Intelligence and Business Strategy:

Leading players in the global Liver Transplantation Market, including healthcare institutions, pharmaceutical companies, and medical device manufacturers, focus on research and development to improve transplant success rates and patient outcomes. Companies invest in developing advanced organ preservation solutions, artificial liver support devices, and improved immunosuppressants to address transplant-related challenges. Collaborations between transplant centers and biotechnology firms are facilitating new treatment modalities, such as xenotransplantation and bioengineered livers. Additionally, initiatives aimed at increasing organ donation rates and improving accessibility to transplantation services are being implemented to drive market growth.

Key Companies Profiled:

  • Allosource
  • Conatus Pharmaceuticals Inc.
  • Digna Biotech S.L.
  • Dompe Farmaceutici S.p.A.
  • Isogenis, Inc.
  • RedHill Biopharma Ltd.
  • Thompson Surgical
  • Integra Life Sciences
  • Baxter International Inc.
  • XVIVO
  • VirTech Bio

Liver Transplantation Market Research Segmentation

By Product Type:

  • Organ Preservation Solutions
  • Immunosuppressive Drugs
  • Others

By Treatment Type:

  • Liver Transplantation Surgery
  • Post-Surgery Anti-Rejection Treatment
  • Cyclosporine
  • Tacrolimus
  • Sirolimus Prednisone Azathioprine
  • Mycophenolate Mofetil

By End-use:

  • Hospitals
  • Adult Liver Transplantation Centers
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Liver Transplantation Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Type Lifecycle Analysis
  • 2.4. Liver Transplantation Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global Liver Transplantation Market Outlook: Product Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
      • 3.3.3.1. Organ Preservation Solutions
      • 3.3.3.2. Immunosuppressive Drugs
      • 3.3.3.3. Others
  • 3.4. Market Attractiveness Analysis: Product Type
  • 3.5. Global Liver Transplantation Market Outlook: Treatment Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
      • 3.5.3.1. Liver Transplantation Surgery
      • 3.5.3.2. Post-Surgery Anti-Rejection Treatment
      • 3.5.3.3. Cyclosporine
      • 3.5.3.4. Tacrolimus
      • 3.5.3.5. Sirolimus Prednisone Azathioprine
      • 3.5.3.6. Mycophenolate Mofetil
  • 3.6. Market Attractiveness Analysis: Treatment Type
  • 3.7. Global Liver Transplantation Market Outlook: End-use
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-use, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
      • 3.7.3.1. Hospitals
      • 3.7.3.2. Adult liver transplantation centers
      • 3.7.3.3. Ambulatory surgical centers
  • 3.8. Market Attractiveness Analysis: End-use

4. Global Liver Transplantation Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Product Type
    • 5.3.3. By Treatment Type
    • 5.3.4. By End-use
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 5.5.1. Organ Preservation Solutions
    • 5.5.2. Immunosuppressive Drugs
    • 5.5.3. Others
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 5.6.1. Liver Transplantation Surgery
    • 5.6.2. Post-Surgery Anti-Rejection Treatment
    • 5.6.3. Cyclosporine
    • 5.6.4. Tacrolimus
    • 5.6.5. Sirolimus Prednisone Azathioprine
    • 5.6.6. Mycophenolate Mofetil
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 5.7.1. Hospitals
    • 5.7.2. Adult liver transplantation centers
    • 5.7.3. Ambulatory surgical centers
  • 5.8. Market Attractiveness Analysis

6. Europe Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Product Type
    • 6.3.3. By Treatment Type
    • 6.3.4. By End-use
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 6.5.1. Organ Preservation Solutions
    • 6.5.2. Immunosuppressive Drugs
    • 6.5.3. Others
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 6.6.1. Liver Transplantation Surgery
    • 6.6.2. Post-Surgery Anti-Rejection Treatment
    • 6.6.3. Cyclosporine
    • 6.6.4. Tacrolimus
    • 6.6.5. Sirolimus Prednisone Azathioprine
    • 6.6.6. Mycophenolate Mofetil
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 6.7.1. Hospitals
    • 6.7.2. Adult liver transplantation centers
    • 6.7.3. Ambulatory surgical centers
  • 6.8. Market Attractiveness Analysis

7. East Asia Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Product Type
    • 7.3.3. By Treatment Type
    • 7.3.4. By End-use
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 7.5.1. Organ Preservation Solutions
    • 7.5.2. Immunosuppressive Drugs
    • 7.5.3. Others
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 7.6.1. Liver Transplantation Surgery
    • 7.6.2. Post-Surgery Anti-Rejection Treatment
    • 7.6.3. Cyclosporine
    • 7.6.4. Tacrolimus
    • 7.6.5. Sirolimus Prednisone Azathioprine
    • 7.6.6. Mycophenolate Mofetil
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 7.7.1. Hospitals
    • 7.7.2. Adult liver transplantation centers
    • 7.7.3. Ambulatory surgical centers
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Treatment Type
    • 8.3.4. By End-use
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 8.5.1. Organ Preservation Solutions
    • 8.5.2. Immunosuppressive Drugs
    • 8.5.3. Others
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 8.6.1. Liver Transplantation Surgery
    • 8.6.2. Post-Surgery Anti-Rejection Treatment
    • 8.6.3. Cyclosporine
    • 8.6.4. Tacrolimus
    • 8.6.5. Sirolimus Prednisone Azathioprine
    • 8.6.6. Mycophenolate Mofetil
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 8.7.1. Hospitals
    • 8.7.2. Adult liver transplantation centers
    • 8.7.3. Ambulatory surgical centers
  • 8.8. Market Attractiveness Analysis

9. Latin America Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Treatment Type
    • 9.3.4. By End-use
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 9.5.1. Organ Preservation Solutions
    • 9.5.2. Immunosuppressive Drugs
    • 9.5.3. Others
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 9.6.1. Liver Transplantation Surgery
    • 9.6.2. Post-Surgery Anti-Rejection Treatment
    • 9.6.3. Cyclosporine
    • 9.6.4. Tacrolimus
    • 9.6.5. Sirolimus Prednisone Azathioprine
    • 9.6.6. Mycophenolate Mofetil
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 9.7.1. Hospitals
    • 9.7.2. Adult liver transplantation centers
    • 9.7.3. Ambulatory surgical centers
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Liver Transplantation Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By Treatment Type
    • 10.3.4. By End-use
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2025 - 2032
    • 10.5.1. Organ Preservation Solutions
    • 10.5.2. Immunosuppressive Drugs
    • 10.5.3. Others
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2025 - 2032
    • 10.6.1. Liver Transplantation Surgery
    • 10.6.2. Post-Surgery Anti-Rejection Treatment
    • 10.6.3. Cyclosporine
    • 10.6.4. Tacrolimus
    • 10.6.5. Sirolimus Prednisone Azathioprine
    • 10.6.6. Mycophenolate Mofetil
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-use, 2025 - 2032
    • 10.7.1. Hospitals
    • 10.7.2. Adult liver transplantation centers
    • 10.7.3. Ambulatory surgical centers
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Immunosuppressive Drugs
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Allosource
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Conatus Pharmaceuticals Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Digna Biotech S.L.
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Dompe Farmaceutici S.p.A.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Isogenis, Inc.
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. RedHill Biopharma Ltd.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Thompson Surgical
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Integra Life Sciences
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Baxter International Inc.
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. XVIVO
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. VirTech Bio
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. Vital Therapies
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. HepaTx
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations